An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation ...
Jul 24, 2013
0
0
A pair of University researchers have received a $600,000 CIHR award to develop a bioactive paper that aims to provide an inexpensive, point-of-care diagnostic tool to measure bronchitis in patients with airway diseases, ...
Jul 24, 2013
0
0
Using a novel form of immune-genetic therapy, researchers from Yale School of Medicine and the Jagiellonian University College of Medicine in Poland have successfully inhibited a strong immune allergic inflammatory response ...
Jul 10, 2013
0
0
(Medical Xpress)—Urinary tract infections are among the most common infections acquired in hospitals. Most are linked to catheters that drain urine from the bladder, providing a direct route for bacteria to enter.
Jun 21, 2013
0
0
(Medical Xpress)—Use of antibiotics in early life may increase the risk of developing eczema by up to 40 per cent, according to a new study led by King's College London researchers, published today in the British Journal ...
Jun 20, 2013
0
0
One reason why obese children and teenagers are more likely to have hard-to-control asthma and allergies may be vitamin D deficiency, a new study finds. Results of the study will be presented Tuesday at The Endocrine Society's ...
Jun 17, 2013
0
0
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.
May 24, 2013
0
1
Chidren with asthma in India are being prevented from receiving effective treatment by a range of widely-held myths and misconceptions, says a University of Sydney study.
May 14, 2013
0
0
Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers ...
May 10, 2013
0
0
(HealthDay)—Procysbi (cysteamine bitartrate) delayed-release capsules have been approved by the U.S. Food and Drug Administration to treat nephropathic cystinosis in children (6 years and up) and adults. Since it is intended ...
May 2, 2013
0
0
